The Renal Center

Filter Your Results

 

News

 

Merit Medical Acquires Brightwater Medical

June 17, 2019 -- Merit Medical Systems, Inc. announced that it has acquired Brightwater Medical, Inc. The transaction consists of a $35 million upfront payment and potential e…

Studies Support Medtronic's Renal Denervation System in High-Risk Hypertensive Patients

May 22, 2019 -- Medtronic announced that late-breaking clinical data from a physician-sponsored clinical trial using the company's Symplicity renal denervation (RDN) syste…

BD Launches UltraScore 014 Focused Force PTA Balloon

April 1, 2019 -- BD (Becton, Dickinson and Company) announced the launch of its UltraScore 014 Focused Force percutaneous transluminal angioplasty (PTA) balloon. The device is…

Six-Month "On-Medication" Results Presented From RADIANCE-HTN SOLO Trial

March 17, 2019 -- ReCor Medical, Inc. announced the 6-month "on-medication" results from the RADIANCE-HTN SOLO clinical trial of the company's Paradise renal den…

BD’s WavelinQ 4-F endoAVF System Receives FDA 510(k) Clearance

February 13, 2019 -- BD (Becton, Dickinson and Company) announced that it has received FDA 510(k) clearance for its WavelinQ 4-F endoAVF system, which allows the creation of a…

New Appropriate Use Criteria Address Peripheral Artery Interventions

January 16, 2019 -- The American College of Cardiology (ACC) announced that the "2018 Appropriate Use Criteria for Peripheral Artery Intervention" document was publi…

Study Evaluates Strength of Evidence Underlying the AHA/ACC Guidelines on Treating Peripheral Vascular Disease

January 16, 2019 -- Findings from a study evaluating the evidence base supporting the American Heart Association (AHA)/American College of Cardiology (ACC) guidelines on perip…

Financing Will Support Global Clinical Program for Ablative Solutions' Peregrine Renal Denervation Technology

January 9, 2019 -- Ablative Solutions, Inc. announced the first close of its $77 million Series D funding round. Funds from the round will be used to complete clinical trials …

 

advertisement

US Device Guide

The Endovascular Today Device Guide offers a searchable, comprehensive listing of the available vascular interventional devices in the United States.

 
 

Contact Info

For advertising rates and opportunities, contact:
Craig McChesney
484-581-1816
cmcchesney@bmctoday.com

Stephen Hoerst
484-581-1817
shoerst@bmctoday.com

Charles Philip
484-581-1873
cphillip@bmctoday.com

About Endovascular Today

Endovascular Today is a publication dedicated to bringing you comprehensive coverage of all the latest technology, techniques, and developments in the endovascular field. Our Editorial Advisory Board is composed of the top endovascular specialists, including interventional cardiologists, interventional radiologists, vascular surgeons, neurologists, and vascular medicine practitioners, and our publication is read by an audience of more than 22,000 members of the endovascular community.